Experts Discuss Effects of Cancer on Memory and Thinking at Free Symposium
CINCINNATIThe University of Cincinnati Cancer and Neuroscience Institutes are holding a free seminar Saturday, Sept. 12, to educate patients and the community on the effect of cancer therapy on memory loss and critical thinking.
The event, which will take place from 8 a.m. to noon, will involve presentations from and interactive discussions with oncology and neuroscience experts.
"The diagnosis of cancer is accompanied by fear and uncertainty, and while much of the focus is on the prognosis of the disease, the perceived effects of the treatment also cause a great deal of anxiety, says Luke Pater, MD, a UC Health radiation oncologist, assistant professor at UC and member of the institutes who is speaking at the event.
"Neurocognitive effects of anti-cancer therapies have long been recognized. The term chemobrain has been assigned to cognitive delays that patients experience following the administration of chemotherapy. A greater understanding of how different doses of radiation and exposures to different regions of the brain have evolved which has led to new approaches in how patients are treated to minimize side-effects on memory and cognition.
"We hope that this event will educate patients on advances being made in this regard and allow them to ask questions about both cancer treatment and effects.
In addition to a presentation by Pater which will focus on ways to minimize cognitive changes after radiotherapy, experts will discuss memory loss and cancer, mood and mental functioning, the effect of chemotherapy on the brain and ways to minimize cognitive changes after radiotherapy. A free continental breakfast will be offered for attendees.
>> See the full agenda and register
With questions, contact Karen Ramos at 513-558-1530.
Tags
Related Stories
UC radiation oncologist speaks with Local 12 news about clinical trial for head and neck cancer treatment
August 10, 2026
Dr. Sara Medek, a UC radiation oncology professor, speaks with Local 12 news about a new clinical trial aimed at reducing radiation in certain areas while still treating cancer effectively but with fewer painful side effects.
Cancer Center director charts future based on collaboration, AI
August 10, 2026
David Gius, MD, PhD, was featured in a Cincinnati Business Courier article and The Cancer Letter’s “The Directors" podcast discussing his priorities and goals as he recently took the helm as director of the University of Cincinnati Cancer Center.
Bidirectional link between oral, kidney health calls for patient education, access
August 4, 2026
Despite growing awareness of the connection between oral health and chronic health conditions, patient awareness and access to dental care remain limited, according to University of Cincinnati experts who recently spoke with Healio | Nephrology News & Issues.